Assessment of recurrence of non-small cell lung cancer after therapy using CT and Integrated PET/CT.

CONCLUSIONS: FDG PET-CT was the best method to differentiate recurrent bronchogenic carcinoma from inflammatory lesions, especially at post-therapeutic sites. It has been shown that PET-CT is more accurate method than CT in recurrent NSCLC. PET-CT results had a further impact on the clinical management and treatment planning.
PMID: 23609428 [PubMed - in process]

Source: Pneumonologia i Alergologia Polska - May 26, 2013 Category: Respiratory Medicine Authors: Opoka L, Szołkowska M, Podgajny Z, Kunikowska J, Barańska I, Błasińska-Przerwa K, Jakubowska L, Rudziński P, Bestry I, Roszkowski-Śliż K Tags: Pneumonol Alergol Pol Source Type: research